Category: Hematology & Oncology
North America Hematology & Oncology
-
2022-2026 Canada Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; ... Read More
-
2022-2026 North America Cancer Diagnostics Market Opportunities for Major Tumor Markers: US, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and ... Read More
-
2022-2026 US Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer diagnostics markets, reviews current and emerging assays; analyzes potential ... Read More
-
U.S. Cancer Treatment Market - Industry Trends and Forecast to 2029
... report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation: U.S. Cancer Treatment Market, By Cancer Type (Breast Cancer, Colorectal ... Read More
-
The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)
... and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed. Companies covered Include: cfDNA-based Liquid Biopsy Adaptive Biotechnologies Biodesix Epigenomics ... Read More